Related Experiment Video
Updated: Jun 5, 2026

Assessment of Oxidative Damage in the Primary Mouse Ocular Surface Cells/Stem Cells in Response to Ultraviolet-C (UV-C) Damage
Published on: February 15, 2020
Emerging role of antioxidants in the protection of uveitis complications
U C S Yadav1, N M Kalariya, K V Ramana
1Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, 77555-0647, USA.
Abstract:
Current understanding of the role of oxidative stress in ocular inflammatory diseases indicates that antioxidant therapy may be important to optimize the treatment. Recently investigated antioxidant therapies for ocular inflammatory diseases include various vitamins, plant products and reactive oxygen species scavengers. Oxidative stress plays a causative role in both non-infectious and infectious uveitis complications, and novel strategies to diminish tissue damage and dysfunction with antioxidant therapy may ameliorate visual complications. Preclinical studies with experimental animals and cultured cells demonstrate significant anti-inflammatory effects of a number of promising antioxidant agents. Many of these antioxidants are under clinical trial for various inflammatory diseases other than uveitis such as cardiovascular, rheumatoid arthritis and cancer. Well planned interventional clinical studies in the field of ocular inflammation will be necessary to sufficiently investigate the potential medical benefits of antioxidant therapies for uveitis. This review summarizes the recent investigations of novel antioxidant agents for ocular inflammation, with selected studies focused on uveitis.
Insights
Antioxidant therapies show promise for treating ocular inflammatory diseases like uveitis by reducing oxidative stress and tissue damage. Further clinical trials are needed to confirm their effectiveness in improving visual outcomes.
Area of Science:
- Ophthalmology
- Immunology
- Pharmacology
Background:
- Oxidative stress is implicated in the pathogenesis of ocular inflammatory diseases, including uveitis.
- Current treatments may not fully address the role of oxidative stress in disease progression and visual complications.
Purpose of the Study:
- To review recent investigations into novel antioxidant agents for ocular inflammation.
- To highlight the potential of antioxidant therapies in managing uveitis and related visual impairments.
Main Methods:
- Review of preclinical studies (animal models, cell cultures) on antioxidant agents.
- Analysis of clinical trial data for antioxidants in various inflammatory conditions, including uveitis.
Main Results:
- Preclinical studies demonstrate significant anti-inflammatory effects of various antioxidant agents.
- Several antioxidants show potential for mitigating tissue damage and dysfunction in ocular inflammation.
- Many promising antioxidants are currently in clinical trials for other inflammatory diseases.
Conclusions:
- Antioxidant therapy represents a potential strategy to optimize treatment for ocular inflammatory diseases.
- Well-designed clinical studies are essential to validate the medical benefits of antioxidant therapies for uveitis.
Related Concept Videos
Radical Autoxidation
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Diabetic Retinopathy
